Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis

Muscle and Nerve

Volumn 45, Issue 1, 2012, Pages 55-59

  Mendias, Christopher L ^a   Gumucio, Jonathan P ^a   Davis, Max E ^a   Bromley, Caleb W ^a   Davis, Carol S ^a   Brooks, Susan V ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Atrogin 1; Fibroblasts; Muscle contractility; Scleraxis; Type i collagen

Indexed keywords

ATROGIN 1; PROCOLLAGEN; SCLERAXIS; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HISTOLOGY; IMMUNOBLOTTING; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE CONTRACTION; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; COLLAGEN TYPE I; FIBROSIS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCULAR ATROPHY; SKP CULLIN F-BOX PROTEIN LIGASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84555187471     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22232     Document Type: Article

References (41)

1. Anzano MA, Roberts AB, Smith JM, Sporn MB, De Larco JE. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci USA 1983;80:6264-6268.
2. Heldin C-H. Development and possible clinical use of antagonists for PDGF and TGF-beta. Ups J Med Sci 2004;109:165-178.
3. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004;18:816-827.
4. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004;164:1007-1019.
5. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
6. Zugmaier G, Paik S, Wilding G, Knabbe C, Bano M, Lupu R, et al. Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 1991; 51:3590-3594.
7. Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze-Mosgau S, et al. TGF-beta and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 2009;1792:746-756.
8. Chen Y-W, Nagaraju K, Bakay M, McIntyre O, Rawat R, Shi R, Hoffman EP. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology 2005;65: 826-834.
9. Kollias HD, McDermott JC. Transforming growth factor-beta and myostatin signaling in skeletal muscle. J Appl Physiol 2008;104: 579-587.
10. ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004;29:265-273.
11. Hopkins DR, Keles S, Greenspan DS. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol 2007;26:508-523.
12. Carmeli E, Moas M, Reznick AZ, Coleman R. Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 2004;29: 191-197.
13. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004;287:C834-843.
14. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-1708.
15. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001;98:14440-14445.
16. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004;117:399-412.
17. McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ling N, et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol 2006;209:501-514.
18. Pryce BA, Brent AE, Murchison ND, Tabin CJ, Schweitzer R. Generation of transgenic tendon reporters, ScxGFP and ScxAP, using regulatory elements of the scleraxis gene. Dev Dyn 2007;236:1677-1682.
19. Edom-Vovard F, Duprez D. Signals regulating tendon formation during chick embryonic development. Dev Dyn 2004;229:449-457.
20. Léjard V, Brideau G, Blais F, Salingcarnboriboon R, Wagner G, Roehrl MH, et al. Scleraxis and NFATc regulate the expression of the pro-alpha 1(I) collagen gene in tendon fibroblasts. J Biol Chem 2007;282:17665-17675.
21. Murchison ND, Price BA, Conner DA, Keene DR, Olson EN, Tabin CJ, et al. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development 2007;134:2697-26708.
22. Pryce BA, Watson SS, Murchison ND, Staverosky JA, Dünker N, Schweitzer R. Recruitment and maintenance of tendon progenitors by TGF-beta signaling are essential for tendon formation. Development 2009;136:1351-1361.
23. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol 2006;101:898-905.
24. Faulkner J, Claflin D, McCully K, Jones D. Contractile properties of bundles of fiber segments from skeletal muscles. Am J Physiol Cell Physiol 1982;243:C66.
25. Allen RE, Boxhorn LK. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J Cell Physiol 1987; 133:567-572.
26. Allen RE, Boxhorn LK. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 1989;138:311-315.
27. Allen RE, Temm-Grove CJ, Sheehan SM, Rice G. Skeletal muscle satellite cell cultures. Methods Cell Biol 1997;52:155-176.
28. Li X, McFarland DC, Velleman SG. Transforming growth factorbeta1- induced satellite cell apoptosis in chickens is associated with beta1 integrin-mediated focal adhesion kinase activation. Poult Sci 2009;88:1725-1734.
29. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002;277:49831-49840.
30. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003;162:1135-1147.
31. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001;91:534-551.
32. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 2009;296:C1248-1257.
33. Aoyama Y, Urushiyama S, Yamada M, Kato C, Ide H, Higuchi S, et al. MFB-1, an F-box-type ubiquitin ligase, regulates TGF-beta signalling. Genes Cells 2004;9:1093-1101.
34. Noirez P, Torres S, Cebrian J, Agbulut O, Peltzer J, Butler-Browne G, et al. TGF-beta1 favors the development of fast type identity during soleus muscle regeneration. J Muscle Res Cell Motil 2006;27: 1-8.
35. Smith CA, Stauber F, Waters C, Alway SE, Stauber WT. Transforming growth factor-beta following skeletal muscle strain injury in rats. J Appl Physiol 2007;102:755-761.
36. Philippou A, Maridaki M, Koutsilieris M. The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration. In Vivo 2008;22:735-750.
37. Taniguti AP, Pertille A, Matsumura CY, Santo Neto H, Marques MJ. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-beta1 blocker. Muscle Nerve 2011;43:82-87.
38. Chan Y-S, Li Y, Foster W, Fu FH, Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 2005;33:43-51.
39. Chan Y-S, Li Y, Foster W, Horaguchi T, Somogyi G, Fu FH, Huard J. Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol 2003;95:771-780.
40. Nozaki M, Li Y, Zhu J, Ambrosio F, Uehara K, Fu FH, Huard J. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med 2008;36:2354-2362.
41. Middaugh CR, Mach H, Burke CJ, Volkin DB, Dabora JM, Tsai PK, et al. Nature of the interaction of growth factors with suramin. Biochemistry 1992;31:9016-9024.